Literature DB >> 8733586

Inhibition of nitrergic relaxations by a selective inhibitor of the soluble guanylate cyclase.

S Cellek1, L Kasakov, S Moncada.   

Abstract

1. The actions of 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ), a specific inhibitor of the soluble guanylate cyclase (SGC), were investigated in the rabbit anococcygeus muscle. 2. ODQ (1 nM-1 microM) inhibited in a concentration-dependent manner the relaxations induced by electrical field stimulation (EFS; 50 V, 0.3 ms duration, 1 Hz, for 5 s, every 120 s). 3. ODQ (1 microM) also inhibited the relaxations elicited by EFS (50 V, 0.3 ms duration, 1, 2.5, 5, 10 Hz, for 5 s) and sodium nitroprusside (SNP; 1 microM) without affecting those induced by isoprenaline (1 microM), atrial natriuretic peptide (ANP; 100 nM) or an analogue of cyclic GMP (8-pCPT-cyclic GMP; 500 microM). 4. ODQ (1 microM) inhibited the elevations in the concentration of cyclic GMP induced by SNP or EFS, but not by ANP. ODQ did not affect the concentrations of cyclic AMP. 5. Nitrergic relaxation in this tissue appears, therefore, to be mediated via activation of SGC.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8733586      PMCID: PMC1909488          DOI: 10.1111/j.1476-5381.1996.tb15376.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

Review 1.  Nitric oxide as a neurotransmitter in peripheral nerves: nature of transmitter and mechanism of transmission.

Authors:  M J Rand; C G Li
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

2.  LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase.

Authors:  A Mülsch; R Busse; S Liebau; U Förstermann
Journal:  J Pharmacol Exp Ther       Date:  1988-10       Impact factor: 4.030

3.  Release of nitric oxide evoked by nerve stimulation in guinea-pig intestine.

Authors:  N P Wiklund; A M Leone; L E Gustafsson; S Moncada
Journal:  Neuroscience       Date:  1993-04       Impact factor: 3.590

4.  Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.

Authors:  J Garthwaite; E Southam; C L Boulton; E B Nielsen; K Schmidt; B Mayer
Journal:  Mol Pharmacol       Date:  1995-08       Impact factor: 4.436

5.  cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.

Authors:  M A Moro; R J Russel; S Cellek; I Lizasoain; Y Su; V M Darley-Usmar; M W Radomski; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

6.  Cyclic GMP mediates neurogenic relaxation in the bovine retractor penis muscle.

Authors:  A Bowman; A H Drummond
Journal:  Br J Pharmacol       Date:  1984-04       Impact factor: 8.739

Review 7.  Neuronal nitric oxide in the gut.

Authors:  S J Brookes
Journal:  J Gastroenterol Hepatol       Date:  1993 Nov-Dec       Impact factor: 4.029

8.  Characterization of nitrergic neurotransmission during short- and long-term electrical stimulation of the rabbit anococcygeus muscle.

Authors:  L Kasakov; S Cellek; S Moncada
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

9.  Role of endothelium-derived nitric oxide in the regulation of blood pressure.

Authors:  D D Rees; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

10.  Inhibition of nitric oxide synthesis by methylene blue.

Authors:  B Mayer; F Brunner; K Schmidt
Journal:  Biochem Pharmacol       Date:  1993-01-26       Impact factor: 5.858

View more
  12 in total

1.  Nitrergic control of peripheral sympathetic responses in the human corpus cavernosum: a comparison with other species.

Authors:  S Cellek; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Inhibitors of phosphodiesterase 5 (PDE 5) inhibit the nerve-induced release of nitric oxide from the rabbit corpus cavernosum.

Authors:  K Hallén; N P Wiklund; L E Gustafsson
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

3.  Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): potential role of cyclin D1.

Authors:  S Pervin; R Singh; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  Investigation of the interaction between nitric oxide and vasoactive intestinal polypeptide in the guinea-pig gastric fundus.

Authors:  J M Dick; L A Van Geldre; J P Timmermans; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

5.  Tonic inhibitory action by nitric oxide on spontaneous mechanical activity in rat proximal colon: involvement of cyclic GMP and apamin-sensitive K+ channels.

Authors:  F Mulè; S D'Angelo; R Serio
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

6.  Characterization of the non-nitrergic NANC relaxation responses in the rabbit vaginal wall.

Authors:  Tom Ziessen; Salvador Moncada; Selim Cellek
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

7.  Failure of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes.

Authors:  J W Wegener; E I Closs; U Förstermann; H Nawrath
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

8.  Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.

Authors:  Haroldo A Toque; Fernanda B M Priviero; Saiprasad M Zemse; Edson Antunes; Cleber E Teixeira; R Clinton Webb
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-10-15       Impact factor: 2.557

9.  Purines and pyrimidines are not involved in NANC relaxant responses in the rabbit vaginal wall.

Authors:  Tom Ziessen; Selim Cellek
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

10.  Mechanisms underlying maternal venous adaptation in pregnancy.

Authors:  Cresta Wedel Jones; Maurizio Mandala; Carolyn Barron; Ira Bernstein; George Osol
Journal:  Reprod Sci       Date:  2009-03-24       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.